Cargando…

Prognostic value of HLA class I expression in patients with colorectal cancer

BACKGROUND: Prognostic factors are useful for determination of the therapeutic strategy and follow-up examination after curative operation in cancer treatment. The immunological state of the host can influence the prognosis for cancer patients as well as the features of the cancer. Human lymphocyte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwayama, Yuji, Tsuruma, Tetsuhiro, Mizuguchi, Toru, Furuhata, Tomohisa, Toyota, Nobuhiko, Matsumura, Masayuki, Torigoe, Toshihiko, Sato, Noriyuki, Hirata, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336735/ https://www.ncbi.nlm.nih.gov/pubmed/25889416 http://dx.doi.org/10.1186/s12957-015-0456-2

Ejemplares similares

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer
por: Tsuruma, Tetsuhiro, et al.
Publicado: (2008)

Case report: Long-term survival of a pancreatic cancer patient immunized with an SVN-2B peptide vaccine
por: Shima, Hiroaki, et al.
Publicado: (2018)

ST6GALNAC1 plays important roles in enhancing cancer stem phenotypes of colorectal cancer via the Akt pathway
por: Ogawa, Tadashi, et al.
Publicado: (2017)

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer
por: Tsuruma, Tetsuhiro, et al.
Publicado: (2004)

Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue
por: Hirama, Tomomi, et al.
Publicado: (2021)

Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients
por: Hiraoka, Nobuyoshi, et al.
Publicado: (2020)

Prognostic value of HLA class I expression in patients with oral squamous cell carcinoma
por: Koike, Kazushige, et al.
Publicado: (2020)

Characterization of CD8(+) T-cell responses to non-anchor-type HLA class I neoantigens with single amino-acid substitutions
por: Shinkawa, Tomoyo, et al.
Publicado: (2021)

HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor
por: Tsukahara, Tomohide, et al.
Publicado: (2009)

Randomized phase II trial of survivin 2B peptide vaccination for patients with HLA‐A24‐positive pancreatic adenocarcinoma
por: Shima, Hiroaki, et al.
Publicado: (2019)

Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients
por: Kobayashi, Jun-ichi, et al.
Publicado: (2009)

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

Clinical implication of HLA class I expression in breast cancer
por: Kaneko, Koichi, et al.
Publicado: (2011)

Development of an artificial antibody specific for HLA/peptide complex derived from cancer stem-like cell/cancer-initiating cell antigen DNAJB8
por: Tadano, Hiroki, et al.
Publicado: (2020)

SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity
por: Yajima, Yuki, et al.
Publicado: (2023)

Immunohistological analysis of pancreatic carcinoma after vaccination with survivin 2B peptide: Analysis of an autopsy series
por: Kubo, Terufumi, et al.
Publicado: (2019)

Heat shock protein 90 targets a chaperoned peptide to the static early endosome for efficient cross-presentation by human dendritic cells
por: Tanaka, Tsutomu, et al.
Publicado: (2015)

High-resolution analysis of HLA class I alterations in colorectal cancer
por: Dierssen, Jan Willem F, et al.
Publicado: (2006)

Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer
por: Hashimoto, Akari, et al.
Publicado: (2014)

The Molecular Pathogenesis and Clinical Implications of Hepatocellular Carcinoma
por: Meguro, Makoto, et al.
Publicado: (2011)

A quest for therapeutic antigens in bone and soft tissue sarcoma
por: Kawaguchi, Satoshi, et al.
Publicado: (2005)

Cancer-associated oxidoreductase ERO1-α promotes immune escape through up-regulation of PD-L1 in human breast cancer
por: Tanaka, Tsutomu, et al.
Publicado: (2017)

Cancer-associated oxidoreductase ERO1-α drives the production of VEGF via oxidative protein folding and regulating the mRNA level
por: Tanaka, Tsutomu, et al.
Publicado: (2016)

Cytotoxic T lymphocytes: Sniping cancer stem cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2012)

Immune responses to human cancer stem‐like cells/cancer‐initiating cells
por: Hirohashi, Yoshihiko, et al.
Publicado: (2015)

The Expression of Tumor Rejection Antigen on Rat Fetus Fibroblasts Transformed by the ras Oncogene
por: Okubo, Mamoru, et al.
Publicado: (1988)

Natural Antigenic Peptides from Squamous Cell Carcinoma Recognized by Autologous HLA‐DR8–restricted CD4(+) T Cells
por: Kondo, Hiroaki, et al.
Publicado: (2002)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells
por: Morimoto, Y, et al.
Publicado: (2004)

Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells
por: Morimoto, Y, et al.
Publicado: (2004)

Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
por: Reimers, Marlies S, et al.
Publicado: (2014)

Heterozygote advantage at HLA class I and II loci and reduced risk of colorectal cancer
por: Tsai, Ya-Yu, et al.
Publicado: (2023)

HLA Class I Expression and Its Alteration by Preoperative Hyperthermo-Chemoradiotherapy in Patients with Rectal Cancer
por: Sato, Hiro, et al.
Publicado: (2014)

Sclerosing Epithelioid Mesenchymal Neoplasm of the Pancreas: Case Report and Literature Review of the Morphologic Characteristics
por: Shitani, Masahiro, et al.
Publicado: (2021)

Use of endoscopic ultrasound‐guided fine needle aspiration of the pancreas to diagnose a case of primary linitis plastica of the colon with retroperitoneal dissemination
por: Shitani, Masahiro, et al.
Publicado: (2021)

HLA class II transgenic mice: the chance to unravel the basis of HLA class II associations with disease
Publicado: (1994)

Implication of chemo‐resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy
por: Shibayama, Yuji, et al.
Publicado: (2017)

Association of HLA-A and Non-Classical HLA Class I Alleles
por: Carlini, Federico, et al.
Publicado: (2016)

Palladium-Induced Temporal Internalization of MHC Class I Contributes to T Cell-Mediated Antigenicity
por: Ito, Koyu, et al.
Publicado: (2021)

Dnajb8, a Member of the Heat Shock Protein 40 Family Has a Role in the Tumor Initiation and Resistance to Docetaxel but Is Dispensable for Stress Response
por: Yamashita, Masamichi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qe88v32mdhk3308i4qndhrparh